On ECHEMI
Home > Drugs > Yunnan Jinbuhuan (Group) Co., Ltd. Pharmaceutical Branch
Yunnan Jinbuhuan (Group) Co., Ltd. Pharmaceutical Branch
  • Founded in:

    2003-09-28
  • Country:

    China China
  • Address:

    Chongka, Jiangna Town, Yanshan County, Wenshan Zhuang and Miao Autonomous Prefecture, Yunnan Province
  • Tax NO.:

    9153000077048614XN
  • Registered Funds:

    -
  • Email:

Related Drugs
Xuesaitong dripping pills
Total saponins of Panax notoginseng
Name Description Content CAS NO. Registered Holders
Panax notoginsenosides

1. It has anti-cerebral ischemia effect, improves brain edema in rats with multiple cerebral infarctions, promotes glial cell reaction, reduces hippocampal neuronal lesions, protects delayed hippocampal neuronal damage after transient cerebral ischemia in gerbils, reduces the Ca2 content in brain tissue after ischemia, reduces the number of dead neurons, and increases neuronal density; 2. It has anti-myocardial ischemia effect, reduces the symptoms of acute myocardial ischemia in rats induced by isoproterenol, and adjusts the ST-T segment recovery and electrocardiographic inhomogeneity of patients with angina pectoris due to coronary heart disease; 3. It improves blood rheology, reduces whole blood viscosity, plasma viscosity, hematocrit, platelet aggregation rate, slows down erythrocyte sedimentation rate, and reduces fibrinogen content; 4. It improves microcirculation, reduces nail fold microcirculation integral in patients with cerebral infarction and essential hypertension, reduces peri-loop exudation, increases flow rate, reduces red blood cell aggregation and congestion, improves loop clarity, and subsides edema; 5. It has the effect of lowering blood lipids, reducing total cholesterol and triglycerides in patients with type 2 diabetes, and reducing serum triglycerides, cholesterol and low-density lipoprotein levels in patients with angina pectoris and cerebral infarction due to coronary heart disease; 6. It has the effect of resisting free radical damage, increasing the activity of superoxide dismutase in erythrocytes of patients with coronary heart disease, reducing plasma malondialdehyde levels, and reducing serum protein kinase C and aspartate aminotransferase levels.

More

1. It has anti-cerebral ischemia effect, improves brain edema in rats with multiple cerebral infarctions, promotes glial cell reaction, reduces hippocampal neuronal lesions, protects delayed hippocampal neuronal damage after transient cerebral ischemia in gerbils, reduces the Ca2 content in brain tissue after ischemia, reduces the number of dead neurons, and increases neuronal density; 2. It has anti-myocardial ischemia effect, reduces the symptoms of acute myocardial ischemia in rats induced by isoproterenol, and adjusts the ST-T segment recovery and electrocardiographic inhomogeneity of patients with angina pectoris due to coronary heart disease; 3. It improves blood rheology, reduces whole blood viscosity, plasma viscosity, hematocrit, platelet aggregation rate, slows down erythrocyte sedimentation rate, and reduces fibrinogen content; 4. It improves microcirculation, reduces nail fold microcirculation integral in patients with cerebral infarction and essential hypertension, reduces peri-loop exudation, increases flow rate, reduces red blood cell aggregation and congestion, improves loop clarity, and subsides edema; 5. It has the effect of lowering blood lipids, reducing total cholesterol and triglycerides in patients with type 2 diabetes, and reducing serum triglycerides, cholesterol and low-density lipoprotein levels in patients with angina pectoris and cerebral infarction due to coronary heart disease; 6. It has the effect of resisting free radical damage, increasing the activity of superoxide dismutase in erythrocytes of patients with coronary heart disease, reducing plasma malondialdehyde levels, and reducing serum protein kinase C and aspartate aminotransferase levels.

0
Panax notoginseng Guanxinning mixture
Panax notoginseng, ginseng essence.
Name Description Content CAS NO. Registered Holders
NOTOGINSENG RADIX ET RHIZOMA

0
Ginseng essence

0
Panax notoginseng capsule
Panax notoginseng root.
Name Description Content CAS NO. Registered Holders
Three seven roots

0
Compound Danshen Capsules
Salvia miltiorrhiza, Panax notoginseng, and borneol.
Name Description Content CAS NO. Registered Holders
Salvia Root P.E Tanshinone IIA 20%

Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids

More

Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids

0
NOTOGINSENG RADIX ET RHIZOMA

Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids

More

Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids

0
Borneol

Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids

More

Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids

507-70-0 1
Panax Notoginseng Guanxinning Capsules
Panax notoginseng.
Name Description Content CAS NO. Registered Holders
NOTOGINSENG RADIX ET RHIZOMA

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.